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Abstract 
Microinvasive squamous cell cervival carcinoma is characterized by an exceptional 
incidence of lymph nodal metastasis. We report the case of a 45-year-old woman 
affected by IA1 squamous cell carcinoma, found to have massive pelvic lymph nodal 
metastasis. After a systematic pelvic and aortic selective lymphadenectomy, at 16 
months of follow-up, she is still disease-free. Patients suitable for conservative therapy 
should be carefully counselled about the established risks and benefits of nondestructive 
treatment options. 
Introduction 
In 1994, the Congress of the International Federation of Gynecology and Obstetrics 
(FIGO) defined stage IA1 squamous cell carcinoma of the cervix as microscopic tumor 
with stromal invasion no greater than 3 mm in depth and 7 mm in width [1]. The 
standard treatment for this stage of disease consists of a complete removal of the cervix by 
a total abdominal or vaginal hysterectomy [2]. Conservative treatments such as cervical 
conization or trachelectomy are also increasingly proposed and safely performed in cases 
of young women who want to preserve their fertility. These modulated surgical strategies 
have been based on the evidence of favourable long-term outcomes; in fact, for stage IA1 
nodal involvement is exceptional, ranging between 0.5 and 1.9% [3], and excellent  
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survival rates have been observed. We describe the case of a patient with stage IA1 
squamous cell carcinoma with unexpected pelvic lymph node spread. 
Case Report 
We report a 45-year-old woman, gravida 3, para 0, who was referred to our institution for 
menometrorrhagia in August 2006. She underwent pelvic examination, ultrasonographic evaluation and 
colposcopy that showed an irregular transformation zone and a squamocolumnar junction not entirely 
visible. A Pap smear was performed and revealed a high-grade squamous intraepithelial neoplasia (H-
SIL). The patient was subjected to a cold knife conization and the cone specimen, measuring 2.9 × 1.8 
cm, was submitted to the pathology. Histological report confirmed the diagnosis of H-SIL and showed 
the presence of a focal lesion of moderately differentiated squamous cell carcinoma, with a depth of 
stromal invasion ranging between 0.9 and 2 mm and a lateral spread of 0.6 mm; apical resection margin 
and lymph-vascular space invasion (LVSI) were both negative. 
Treatment options were discussed at length with the patient, including expectant management; she 
expressed a strong desire to avoid any future risk for recurrent disease. In October, the patient 
underwent total hysterectomy with bilateral adnexectomy. During surgery one suspicious right pelvic 
node was resected. Histological exam reported a negative uterine tissue and, unexpectedly, a metastatic 
squamous cervical carcinoma involving the external iliac node was detected (fig. 1). 
The patient was scheduled for a total positron emission tomography-computed tomography 
(PET/CT) scan that showed a high uptake at the bilateral external ilium, confirming the presence of 
lymph nodal metastasis. In November 2006, the patient underwent relaparotomy and systematic pelvic 
lymphadenectomy plus radical parametrectomy. Two groups of pelvic nodes (superficial obturators, 
interiliac and external iliac nodes bilaterally) were sent for frozen section analysis in order to determine 
the tailoring of parametrectomy. Histological exam revealed a positive left nodes and Piver III–IV 
parametrectomy was performed. Lymphadenectomy was completed, removing deep obturator, 
presacral, internal and common iliac bilateral nodes, and a selective aortic lymphadenectomy. Definitive 
histological report revealed 4 metastatic bulky pelvic nodes of 3 cm with extracapsular involvement.  
For further investigation one specimen each from cervical tissue and from lymph nodal metastases 
were tested for human papillomavirus (HPV) genotypes and human papillomavirus type 18 was 
detected in both. 
An adjuvant chemotherapy with platinum 75 mg/mq p1q28 and paclitaxel 175 mg/mq p1q28 from 
January until May 2007 was administered. Up to now, after 35 months of follow-up, the patient is still 
disease-free. 
Discussion 
The more recent knowledge and attention concerning screening programs and 
preventive medicine have achieved a very early diagnosis of cervical cancer. Nevertheless, 
although many efforts have been done in the last decade to unify the definitions, the 
management and the treatment of this medical condition, several aspects still remain 
controversial. 
The current definition of early-stage cervical cancer has been definitely estabilished in 
1995, when the FIGO society defined stage IA1 squamous cell carcinoma of the cervix as a 
stromal invasion no greater than 3 mm in depth and 7 mm in width, meanwhile stage IA2 
was defined as a stromal invasion with a depth of 3.0 mm to ≤5.0 mm, and an extension 
of ≤7.0 mm [1]. For stage IA1, nodal involvement is exceptional, ranging between 0.5 and 
1.9% [3], and excellent survival rates have been observed. For all these reasons, 
conservative treatment such as cervical conization or trachelectomy have been used 
increasingly, besides the traditional extrafascial hysterectomy, in those women who wish 
to preserve their fertility and when surgical margins and LVSI are all negative [4].  
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In this paper we report the unusual case of a 45-year-old patient affected by IA1 
cervical cancer with multiple and extracapsular lymph nodal metastasis. The patient was 
first subjected to extrafascial hysterectomy with selective pelvic lymph nodes dissection; 
subsequently, bulky lymph nodes were noted on imaging findings and lomboaortic 
lymphadenectomy with parametrectomy was performed. The final histopathologic report 
confirmed the presence of massive nodal involvement, meanwhile cervical tissue was 
disease-free. 
To the best of our knowledge, only few analogous experiences have previously been 
reported in the literature (table 1). According to the literature data, lymph nodal 
involvement should be considered as the most powerful prognostic factor in the early 
cervical cancer; nevertheless, the question whether LVSI can also be esteemed as an 
independent risk variable still remains debated. In our review, when analyzing all the 
available data together with our report, LVSI does not seem to unequivocally correlate 
with the lymph nodal status, nor with the survival data (table 2); in fact, patients with 
LVSI seem to have a better prognosis when compared with those without LVSI; 
additionally, distant lymph nodal metastasis (paraaortic and supraclavicular lymph 
nodes) occur even without LVSI. Consequently, even if it is only a limited review, with 
few available data, the consideration arises that LVSI should be carefully pondered in the 
choice of conservative or destructive treatment. 
It is also remarkable that, according to other experiences [15], the tumor and the 
metastatic tissue were both positive for the presence of HPV type 18, corroborating the 
hypothesis of the correlation between the virus and the aggressivity of the tumor, in term 
of prognosis and outcome. 
Finally, a peculiar aspect of this report is that the preoperative evaluation of lymph 
nodal status was obtained by 
18F-fluorodeoxyglucose (FDG)-PET/CT scan, confirming 
and supporting the increasing evidence reported in the literature that FDG-PET/CT scan 
can be valuable for lymph node staging in patients with early-stage cervical cancer. In fact, 
comparative studies of FDG-PET with either CT or magnetic resonance (MR) imaging for 
depicting lymph node spread [16] have suggested a more significant role for FDG-PET, 
with a specificity of 99.7% and an accuracy of 99.3%. 
This report adds a new case of FIGO stage IA1 cervical cancer with extensive lymph 
nodal spread, to emphasize the possibility of nodal metastases in the setting of 
microinvasive squamous carcinoma. The patients suitable for conservative therapy should 
be accurately selected, with the aid of new diagnostic tools, such as PET/CT for the 
clinical staging and molecular biomarkers for a more reliable prognostic correlation with 
the pathological findings. In any case, this subset of patients should also be carefully 
counselled about the established risks and benefits of nondestructive treatment options. 
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Table 1. Literature review of lymph node metastasis in microinvasive cervical cancer IA1 and 
correlation to LVSI+ 
Author, year  No.of cases  LND   0Positive LNs (%)  LVSI+  Histotype 
Case series          
Bohm et al., 1976 [5]  069  056  04 (7.14)  2  Squamous  
Seski et al., 1977 [6]  054  037  01 (2.70)  0  Squamous 
Hasumi et al., 1980 [7]  106  106  01 (0.9)  3  Squamous 
Maiman et al., 1988 [8]  083  065  01 (1.5)  5  Squamous 
Tsukamoto et al., 1989 [9]  103  103  01 (0.9)  4  Squamous 
Elliott et al., 2000 [3]  387  121  01 (0.8)  N.A.  Squamous 
Smith et al., 2002 [10]  200  070  02 (2.85)  –  Adenocarcinoma/
adenosquamous 
Lee and Lee, 2006 [11]  174  116  03 (2.58)  7  Squamous 
Total     14     
Case report          
Collins et al., 1989 [12]  001  001  01 0  Squamous 
Nagarsheth et al., 2000 [13]  001  001  01 0  Adenocarcinoma
Argenta et al., 2005 [14]  001  001  01 0  Adenosquamous 
Total     03    
LND = lymph node dissection; LNs = lymph nodes; – = not reported; LVSI = lymph-vascular space 
invasion; N.A. = not avaible. 
 
 
Table 2. Analysis of patients with positive nodes 
Author, year  Pts. with  
positive  
LNs 
Lymph nodal sites  LVSI  Status  Histotype 
Bohm et al., 1976 [5]  4  3 Left obturator 
1 Left external iliac, 
right external iliac 
2 patients + 
2 patients – 
1 DOD at 2 years and 8 months,  
1 DOD at 6 years and 4 months, 
2 DID 
Squamous 
Seski et al., 1977 [6]  1  Pelvic  N.A.  NED  Squamous 
Hasumi et al., 1980 [7]  1  Pelvic  –  N.A.  Squamous 
Maiman et al., 1988 [8] 1  Pelvic  +  N.A.  Squamous 
Tsukamoto et al., 1989 
[9] 
1  Left internal iliac  +  DID at 7 years  Squamous 
Collins et al., 1989 [12]  1  Pelvic and paraaortic  –  DOD at 7 months  Squamous 
Elliott et al., 2000 [3]  1  N.A.  –  DOD  N.A. 
Nagarsheth et al., 2000 
[13] 
1 Pelvic  –  N.A.  Adenocarcinoma
1 (1)  Pelvic   N.A.  NED at 4 months  Endometrioid 
adenocarcinoma
Smith et al., 2002 [10] 
1 (3)  Pelvic   N.A.  DOD at 12 months  adenosquamous
Argenta et al., 2005 [14] 1  Pelvic and paraaortic  –  NED at 15 months  Adenosquamous
Lee and Lee, 2006 [11]  3  Left supraclavicular  –  DOD at 15 months  Squamous 
    Pelvic   +  NED at 54 months  Squamous 
    Pelvic   –  NED at 60 months  Squamous 
Our case    Pelvic   –  NED at 12 months  Squamous  
NED = no evidence of disease; DOD = died of disease; DID = died of intercurrent disease; LVSI = lymph-vascular space 
invasion; N.A. = not avaible. 
 
 
 
  
Case Rep Oncol 2010;3:176–181 
DOI: 10.1159/000313341 
Published online: June 8, 2010  © 2010 S. Karger AG, Basel 
ISSN 1662–6575 
www.karger.com/cro 
 
 
180
Fig. 1. Lymphatic metastasis in squamous cell cervical carcinoma stage IA1. 
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